Endo Pharmaceuticals
Ballsbridge
About Endo Pharmaceuticals
Endo is a pharmaceutical company that develops and manufactures generics and branded medications for various medical needs, focusing on therapeutic areas such as pain management, urology, and endocrinology. The company offers a range of products, including prescription medications and over-the-counter treatments, aimed at addressing conditions like chronic pain, hormone-related disorders, and other health issues. Endo also engages in research and development to expand its portfolio and improve patient outcomes through innovative therapeutic solutions.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1,001 – 5,000
- Estimated revenue: $1M – $10M
- Total funding: $2.0B
- Funding stage: M&A
- Last round: Post-IPO Equity (May 2024)
- Ticker: nasdaq:ENDP
- Website: endo.com
- Phone: 1-800-462-(3636)
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/endo-pharmaceuticals-191586 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.